| P2093 | author name string | Vallerie V McLaughlin | |
| | Mark D Huffman | |
| P2860 | cites work | Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial | Q28374317 |
| | Clinical classification of pulmonary hypertension. | Q30341846 |
| | Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial. | Q33147483 |
| | Prognosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines | Q35834000 |
| | The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension | Q41768885 |
| | Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study | Q43764381 |
| | Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial | Q43977511 |
| | Oral sildenafil is an effective and specific pulmonary vasodilator in patients with pulmonary arterial hypertension: comparison with inhaled nitric oxide | Q44000686 |
| | Long-term intravenous epoprostenol infusion in primary pulmonary hypertension: prognostic factors and survival. | Q44120529 |
| | Survival in primary pulmonary hypertension: the impact of epoprostenol therapy. | Q44138534 |
| | Beraprost therapy for pulmonary arterial hypertension | Q44487843 |
| | A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension | Q44938984 |
| | Survival in patients with primary pulmonary hypertension. Results from a national prospective registry. | Q52422731 |
| | The cost-effectiveness of lung transplantation. A pilot study. University of Washington Medical Center Lung Transplant Study Group | Q71582116 |
| | The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension | Q77318711 |
| | Bosentan therapy for pulmonary arterial hypertension | Q77801473 |
| | Screening, early detection, and diagnosis of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines | Q80332624 |
| | Pulmonary hypertension | Q80884934 |
| P433 | issue | 6 | |
| P304 | page(s) | 451-458 | |
| P577 | publication date | 2004-12-01 | |
| P1433 | published in | Current treatment options in cardiovascular medicine | Q27714743 |
| P1476 | title | Pulmonary Arterial Hypertension: New Management Options. | |
| P478 | volume | 6 | |